Medical therapy in the management of preterm birth

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue SUPPL. 3, 2009, Pages 72-76

  Meloni, Alessandra ^a   Melis, Michela ^a   Alba, Elisabetta ^a   Deiana, Sara ^a   Atzei, Alessia ^a   Paoletti, Anna Maria ^a   Capobianco, Giampiero ^b   Dessole, Salvatore ^b   Melis, Gian Benedetto ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

NSAIDs; Preterm birth; Progesterone; Short cervix; Tocolytics

Indexed keywords

ATOSIBAN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; INDOMETACIN; ISOXSUPRINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIN; OXYTOCIN ANTAGONIST; OXYTOCIN RECEPTOR; PROGESTERONE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; UTERUS SPASMOLYTIC AGENT;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC THERAPY; ASTHMA; BETA HEMOLYTIC STREPTOCOCCUS; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; DELIVERY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEART PALPITATION; HEARTBURN; HIGH RISK POPULATION; HUMAN; HYDRATION; INJECTION SITE REACTION; KIDNEY FUNCTION; LUNG DYSPLASIA; LUNG EDEMA; MATERNAL MORTALITY; MULTICENTER STUDY; NAUSEA; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; OLIGOHYDRAMNIOS; PATIENT TRANSPORT; PREMATURE LABOR; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROCTITIS; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; THORAX PAIN; THROMBOCYTOPENIA; TOCOLYSIS; TREMOR; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX; UTERUS CONTRACTION; VOMITING;

ADMINISTRATION, INTRAVAGINAL; ADRENERGIC BETA-AGONISTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ITALY; PREGNANCY; PREMATURE BIRTH; PROGESTERONE; PROSPECTIVE STUDIES; RITODRINE; TOCOLYTIC AGENTS; VASOTOCIN;

EID: 70449433075     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050903198256     Document Type: Review

References (27)

1. Amon E. Preterm labor. In: Reece EA, Hobbins JC, editors. Medicine of the fetus and mothers. Philadelphia: Lippincott- Raven; 1999. pp 1529-1579.
2. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD. Preterm birth. In: Williams Obstetrics. 21th ed. International Edition. Mc Graw-Hill Companies Inc., New York, USA; 2001. Chapter 27, pp 689-727.
3. Di Renzo GC, Cabero Roura L; and the European Association of Perinatal Medicine Study Group on "Preterm Birth". Guidelines for the management of spontaneous preterm labor. J Perinat Med 2006;34:359-366.
4. Robertson PA, et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 trough 1986. Am J Obstet Gynecol 1992;166:1629-1634.
5. World Health Organization, Geneva. ICD-10. Second Edition. International Statistical Classification of Disease and Related Health Problems. 10th revision, Vol.2; 1993.
6. To MS, Nicholaides KH. Cervical length at 23 weeks in triplets: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 2000;16:515-518.
7. Ross MG, Eden RD. Preterm labor. Available at: http:// emedicine.medscape.com/article/260998-overview; 2009
8. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000; ISSUE 2, DOI: 10.1002/14651858.CD000065.
9. CDC. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR 2002;51:1-22.
10. Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic therapy: a metaanalysis and decision analysis. Obstet Gynecol 2009;113:585-594.
11. De Heus R, Willem B, Erwich HM, Van Geijn HP, Gyselaers WJ, Hanssens M, Harmark L, Van Holsbeke CD, Duvekot JJ, Schobben FFAM, Wolf H, Visser GHA. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ 2009;338:b744. Downloaded from bmj.com on 8 July 2009.
12. ACOG Committee Opinion n 291. Use of Progesterone to Reduce Preterm Birth Vol. 102, no 5; 2003:1020-1037.
13. Goldenberg GL. The management of preterm labor. ACOG practice bulletin. Int J Gynecol Obstet 2002;100:5 Part 1.
14. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005; Issue 2.
15. Gazzetta Ufficiale della Repubblica Italiana. Modifica degli stampati e del regime di fornitura di specialità medicinali contenenti ritodrina e isoxisuprina. Serie Generale n 166 del 19/7/2003.
16. Royal College of Obstetrician and Gynaecologists. Tocolytic drug for women in preterm labour; 2002; Clinical Guideline No.1.
17. Inoue Y, Yoshizato T, Kawarabayashi T. Investigation of b2- adrenoceptor subtype selectivity and organ specificity for bedoradrine (KUR-1246), a novel tocolytic b-adrenergic receptor stimulant. J Obstet Gynaecol Res 2009;35:405-413.
18. Neri M, Monari F, Valensise H, Vasapollo B, Facchinetti F, Volpe A. Computerized evaluation of fetal heart rate during tocolytic treatment: comparison between Atosiban and Ritodrine. Am J Perinatol 2008;26(4):259-263.
19. Coomarasamy A. Progesterone for the prevention of the preterm birth: a critical evaluation of evidence. Eur J Obstet Gynecol Reprod Biol 2006;129:111-118.
20. Da Fonseca EB, Bttar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebocontrolled double-blind study. Am J Obstet Gynecol 2003; 188:419-424.
21. Meis PJ, et al. Prevention of recurrent preterm delivery by 17 a hydroxyprogesterone caproate. N Eng J Med 2003;348: 2379-2385.
22. DeFranco EA, O'Brien JM, Adair CD, et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007;30:697-705.
23. De Fonseca EB, Ebru C, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with short cervix. N Eng J Med 2007;357:462-469.
24. Romero R, Espinoza J, Kusanovic J, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M. The preterm parturition syndrome. BJOG 2006;113:17-42.
25. Borna S. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. The Royal Aus and NZCOG 2008;48:58-63.
26. Thornton JG. Maintenance tocolysis. BJOG March 2005;112: 118-121.
27. Agenzia Italiana del Farmaco. Tocolitici: farmaci davvero necessari? Bollettino di Informazione sui Farmaci XIV 2007; N. 5.